300633 开立医疗
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.0764.55415.44214.51613.364
总资产报酬率 ROA (%)0.7953.52312.42411.2679.379
投入资产回报率 ROIC (%)0.9424.14014.36013.22911.268

边际利润分析
销售毛利率 (%)60.36463.78367.71166.86667.382
营业利润率 (%)0.6576.03622.39421.69614.929
息税前利润/营业总收入 (%)-2.0114.11220.24119.97318.229
净利润/营业总收入 (%)2.2967.07121.43320.98017.115

收益指标分析
经营活动净收益/利润总额(%)-450.44799.87696.02389.84591.386
价值变动净收益/利润总额(%)23.8283.462-2.7101.3935.902
营业外收支净额/利润总额(%)-7.080-1.137-0.208-0.12715.163

偿债能力分析
流动比率 (X)3.0362.7464.6173.3553.836
速动比率 (X)2.0122.1433.6822.6693.044
资产负债率 (%)24.21927.93416.58422.69722.023
带息债务/全部投入资本 (%)8.74311.7511.8928.8004.165
股东权益/带息债务 (%)1,018.767731.7885,093.5281,016.0202,238.482
股东权益/负债合计 (%)312.895257.992502.980340.596354.069
利息保障倍数 (X)0.766-2.215-9.606-11.77828.865

营运能力分析
应收账款周转天数 (天)42.43234.50531.65941.57156.642
存货周转天数 (天)362.966292.342274.978294.299286.965